Viveka Roychowdhury

The recently held Odisha Pharma Summit 2025, the state’s first dedicated summit focused on pharmaceuticals, medical devices, and life sciences manufacturing, is by all accounts a success.( https://www.expresspharma.in/odisha-pharma-summit-2025-positions-o... See more

We are cost-competitive and aligned with global ESG framework demands From dependence on imported single-use products and containment solutions, India’s biologics sector can today access domestically manufactured SUTs, which can be 20–30 per cent more cos... See more

Healthcare’s fault lines, flash points and the search for balance In spite of the policy friction and flash points ahead in 2026, India’s healthcare sector is predicted to show market resilience By Viveka Roychowdhury On Jan 8, 2026 0 25 Share As India ge... See more

Balancing protection and compliance 2026 must be the year India’s pharma policy and industry align, as policy directives can only be successful if all sections of the industry step up to the challenge If 2025 was defined by US tariffs, predatory pricing +... See more

How MeitY–NASSCOM CoE fuels Easiofy’s AI-imaging leap Easiofy, an AI-powered imaging platform, built by three women founders—Meenal Gupta, Noor Fatma and Sheetal Tarkas – and now deployed across resource- and radiologist-scare areas in India, is proof tha... See more